can you take semaglutide and tirzepatide in the same week I compare two weight loss medications with my patients every single week. Here's what data actually shows. (Ozempic/Wegovy) delivered a 13.7% average weight loss clinical trials. That's significant. But Semaglutide vs Tirzepatide, which is

Most people lose one to three pounds in this window, mostly from reduced calorie intake and some water weight

Obesity affects millions of Americans and takes a toll on both physical health and emotional well-being

Contact your healthcare provider if you experience: Severe or persistent heartburn that does not respond to appropriate treatment within two weeks Difficulty swallowing (dysphagia) or painful swallowing (odynophagia) Weight loss that seems excessive or occurs more rapidly than expected with treatment Persistent nausea or vomiting that prevents adequate nutrition or hydration Vomiting blood or material that looks like coffee grounds Black, tarry stools suggesting gastrointestinal bleeding Severe abdominal pain , particularly if localized to the upper abdomen Right upper abdominal pain, fever, or yellowing of skin/eyes , which may suggest gallbladder disease Signs of dehydration such as extreme thirst, dizziness, or decreased urination after significant vomiting or diarrhea Seek emergency care immediately (call 911) if you experience: Chest pain , especially if accompanied by shortness of breath, sweating, or radiation to the arm or jaw Severe, persistent abdominal pain radiating to the back , which may indicate pancreatitis Pancreatitis is a known risk with GLP-1 receptor agonists including tirzepatide, as noted in the FDA prescribing information

Storage-sensitive reagent : Protect from light during handling

Adverse Event Reporting If you experience a severe or unexpected reaction, discontinue use and seek immediate medical attention

Who should not use semaglutide: Do not use semaglutide if you or any family member has ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)